We have observed
4 EP applications
Andrew John Sharples
has served for within the last five+ years.
(We consider all applications which have an EP A1 or A2 publication dated after December 02, 2013).
Please note, that we only count EP applications,
in which the name of the patent attorney is explicitly mentioned as representative.
These EP applications are:
PYRROLIDINE DERIVATIVES AS SELECTIVE GLYCOSIDASE INHIBITORS AND USES THEREOF
METHODS FOR PREPARATION OF MACROCYCLIC POLYESTER OLIGOMER VIA HETEROGENEOUS CATALYSIS
COLD BLOCK WITH EMBEDDED CHAMBERED BEVERAGE TAP
USE OF GALECTIN-3 FOR DETECTING AND PROGNOSING HEART FAILURE AFTER ACUTE CORONARY SYNDROME